Yoko Shioda

Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study

Akira Morimoto, Yoko Shioda, Toshihiko Imamura et al. · International Journal of Hematology · 2016 · 96 citations

Medicine, Oncology, Pharmacotherapy +10

Nationwide survey of single‐system single site Langerhans cell histiocytosis in Japan

Akira Morimoto, Yasushi Ishida, Nobuhiro Suzuki et al. · Pediatric Blood & Cancer · 2009 · 64 citations

Medicine, Hematology, Pediatrics +12

Follow-up of pediatric patients treated by IVIG for Langerhans cell histiocytosis (LCH)-related neurodegenerative CNS disease

Shinsaku Imashuku, Naoto Fujita, Yoko Shioda et al. · International Journal of Hematology · 2014 · 51 citations

Medicine, Neurology, Pediatrics +13

Inflammatory serum cytokines and chemokines increase associated with the disease extent in pediatric Langerhans cell histiocytosis

Akira Morimoto, Yukiko Oh, Sachie Nakamura et al. · Cytokine · 2017 · 51 citations

Medicine, Immunology, Pathology +17

Neurodegenerative central nervous system disease as late sequelae of Langerhans cell histiocytosis. Report from the Japan LCH Study Group

Shinsaku Imashuku, Yoko Shioda, Ryōji Kobayashi et al. · Haematologica · 2008 · 43 citations · Full text

Medicine, Neurology, Neuroscience +13